Atlas Trials

Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis

Clinical trial NCT05976802 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05976802
Sponsor
Bausch Health Americas, Inc.
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2027-06-01
Primary completion
2029-06-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.